Bey-Dih Chang

Title: Bey-Dih Chang: Innovator in High-Content Screening for Cancer Research

Introduction

Bey-Dih Chang is a notable inventor based in Rensselaer, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of drug screening for cancer and age-related diseases. His innovative approaches have the potential to advance therapeutic strategies and improve patient outcomes.

Latest Patents

Bey-Dih Chang holds a patent for "High-content screening for drugs against cancer and age-related diseases." This invention relates to methods for high-throughput screening for compounds that modulate cell growth or promoter activity. The invention provides the use of cell lines with properly regulated promoter-reporter expression, suitable for high-throughput screening. More particularly, it focuses on identifying compounds that affect cell growth and/or modulate the effect of cell cycle arrest on the function of a promoter that is responsive to cell cycle inhibition. He has 1 patent to his name.

Career Highlights

Bey-Dih Chang is currently associated with Senex Biotechnology, Inc., where he applies his expertise in drug discovery and development. His work is instrumental in advancing the understanding of cellular mechanisms and therapeutic interventions.

Collaborations

Bey-Dih Chang collaborates with Igor B Roninson, a fellow researcher in the field. Their combined efforts contribute to the ongoing research and development of innovative solutions in biotechnology.

Conclusion

Bey-Dih Chang's contributions to high-content screening represent a significant advancement in cancer research. His innovative methods and collaborative efforts continue to pave the way for new therapeutic discoveries.